Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Transplantation

• Publication date

  1998-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199803150-00011PMID 9521201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The long-term course of hepatitis C after kidney transplantation.

  1996cited by this paper
• Long-term outcome of hepatitis C infection after liver transplantation.

  1996cited by this paper
• THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION

  1995cited by this paper
• Hepatitis C virus: the nephrologist's view.

  1995cited by this paper
• Hepatitis C virus infection in renal transplantation.

  1995cited by this paper
• Implications of chronic hepatitis B or hepatitis C infection for renal transplant candidates.

  1995cited by this paper
• Long‐term outcome in kidney transplant patients with hepatitis C (HCV) infection

  1995cited by this paper
• Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C.

  1995cited by this paper
• Outcome of HCV infection after renal transplantation.

  1994cited by this paper
• The impact of hepatitis C virus infection on renal allograft recipients.

  1994cited by this paper
• Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up.

  1993cited by this paper
• HEPATITIS C IS A POOR PROGNOSTIC INDICATOR IN BLACK KIDNEY TRANSPLANT RECIPIENTS

  1993cited by this paper
• HEPATITIS C—ITS PREVALENCE IN END‐STAGE RENAL FAILURE PATIENTS AND CLINICAL COURSE AFTER KIDNEY TRANSPLANTATION

  1993cited by this paper
• Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival--a 5- and 10-year follow-up.

  1993cited by this paper
• Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation.

  1992cited by this paper
• Hepatitis C virus in kidney recipients

  1992cited by this paper
• Hepatitis C virus infection in chronic hepatitis B virus carriers.

  1991cited by this paper
• Chronic hepatitis in kidney allograft recipients.

  1990cited by this paper
• Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma.

  1987cited by this paper

• High risk of hepatic complications in kidney transplantation with chronic hepatitis C virus infection

  2025cites this paper
• The Landscape of Hepatitis C Virus Infection in Pediatric Kidney Transplantation.

  2025cites this paper
• KDIGO 2022 Clinical Practice Guideline FOR the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

  2022cites this paper
• M anagement of HCV infection in chronic kidney disease

  2022cites this paper
• An updated systematic review and meta-analysis on efficacy of Sofosbuvir in treating hepatitis C-infected patients with advanced chronic kidney disease.

  2021cites this paper
• First Asian Kidney Donor Profile Index (KDPI) and Estimated Post‐Transplant Survival (EPTS) models, with validation against US models in Thai population

  2021cites this paper
• Quantification of plasma levels of antiviral drug sofosbuvir and its metabolite GS331007 in patients of chronic hepatitis C with chronic kidney disease using UPLC-MS/MS method

  2020cites this paper
• Current state of kidney transplantation in patients with HIV, hepatitis C, and hepatitis B infection

  2020cites this paper
• Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus.

  2020influential citation
• Outcomes After Direct-Acting Antiviral Therapy Based on Donor Hepatitis C Serostatus Among Hepatitis C Virus-Infected Kidney Transplant Recipients.

  2020cites this paper
• Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice

  2019cites this paper
• Liver Disease Among Renal Transplant Recipients

  2019cites this paper
• 1 Infectious Complications in Kidney Transplantation

  2019cites this paper
• Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.

  2019cites this paper
• KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

  2019cites this paper
• Hepatitis C and kidney transplant: The eradication time of the virus has arrived

  2019cites this paper
• Changing pattern of chronic hepatitis C in renal transplant patients over 20 years.

  2019cites this paper
• Hepatitis C and kidney transplant: The eradication time of the virus has arrived.

  2019cites this paper
• KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

  2018cites this paper
• Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients

  2018cites this paper
• OriginalClinicalScienceçLiver Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States

  2018cites this paper
• Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.

  2018cites this paper
• Hepatitis C: Current Controversies and Future Potential in Solid Organ Transplantation

  2018cites this paper
• Management of Hepatitis C Infection in Kidney Transplantation Candidates and Recipients

  2018cites this paper
• Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients

  2018cites this paper
• Stellungnahme der DGVS zur frühen Nutzenbewertung Elbasvir/Grazoprevir

  2018cites this paper
• Hepatitis C virus status in hemodialysis patients in Menoufia Government, Egypt, five years apart: Do we have any improvement?

  2017cites this paper
• Pancreatic Transplantation

  2017cites this paper
• Malignancies in hepatitis C virus‐positive and ‐negative kidney transplant recipients: A case‐controlled study

  2017cites this paper
• The correlation between renal transplantation and liver carcinoma: a meta-analysis

  2017cites this paper
• Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis

  2017cites this paper
• The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients

  2017cites this paper
• Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost

  2017cites this paper
• Long-term outcomes of hepatitis C virus infected renal allograft recipients

  2017cites this paper
• Current Concepts in Kidney Transplantation 302 Network for Organ Sharing

  2017cites this paper
• Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States

  2017cites this paper
• The Impact of Hepatitis C Virus Infection on the Clinical Course, Short Term and Long–Term Outcome in Renal Transplant Recipients–A Prospective and Retrospective Study

  2017cites this paper
• Importance of Liver Biopsy Findings on Prognosis of Kidney Transplant Patients.

  2016cites this paper
• Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure

  2016cites this paper
• [Infectious and neoplasic complications after kidney transplantation].

  2016cites this paper
• Effect of Hepatitis C Positivity on Survival in Adult Patients Undergoing Heart Transplantation (from the United Network for Organ Sharing Database).

  2016cites this paper
• Use of direct‐acting agents for hepatitis C virus‐positive kidney transplant candidates and kidney transplant recipients

  2016cites this paper
• Infezione da HCV nel paziente dializzato: le nuove cure nei pazienti “difficili”@@@HCV infection and severe renal impairment or end-stage renal disease: new treatments for “difficult” patients

  2016cites this paper
• Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon.

  2016cites this paper
• Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

  2015cites this paper
• Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.

  2015cites this paper
• Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• Management of hepatitis C in patients with chronic kidney disease.

  2015cites this paper
• Kidney Transplantation Threshold in Patients With Hepatitis C: A Decision Analysis Model

  2015cites this paper
• Lack of impact of hepatitis C virus infection on graft survival after kidney transplantation--a Portuguese single-center experience.

  2015cites this paper
• Hepatitis C and its impact on renal transplantation

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• Management of hepatitis C infection in kidney transplant candidates

  2014cites this paper
• Pegylated Interferon Alfa 2a and Small Dose Ribavirin in the Treatment of HCV Genotype 4 in End - Stage Renal Disease

  2014cites this paper
• Hepatitis C virus infection in end‐stage renal disease and kidney transplantation

  2014cites this paper
• Effect of HCV, HIV and Coinfection in Kidney Transplant Recipients: Mate Kidney Analyses

  2014cites this paper
• What are the Management Issues for Hepatitis C in Dialysis Patients?

  2014cites this paper
• Meta‐analysis of observational studies: hepatitis C and survival after renal transplant

  2014cites this paper
• Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C.

  2013cites this paper
• The burden of anti-HCV genotye-4 positivity in renal transplant recipients: 8 years follow-up

  2013cites this paper
• Impacto a corto plazo de la infección por el virus de la hepatitis C en los resultados del trasplante renal en España en el período 1990-2002

  2013cites this paper
• Hepatitis C virus infection in hemodialysis patients.

  2013cites this paper
• Hepatitis C virus and kidney disease.

  2013cites this paper
• Hepatitis C infection and chronic renal diseases

  2013cites this paper
• Hepatitis C Infection in Kidney Transplantion

  2013influential citation
• Hepatitis C Virus and Nonliver Solid Organ Transplantation

  2013cites this paper
• Racial Disparities in Post-Transplant Survival Among Renal Transplant Recipients with Pre-Transplant Hepatitis C Seropositivity

  2013cites this paper
• Campath induction in HCV and HCV/HIV‐seropositive kidney transplant recipients

  2013cites this paper
• Histological evolution of hepatitis C virus infection after renal transplantation

  2012cites this paper
• Acquisition time: A key point of hepatitis C virus- related liver disease in renal transplant recipients

  2012cites this paper
• Use of HCV-Positive Organs in Patients With and Without Chronic HCV

  2012cites this paper
• Kidney transplantation in the patient with hepatitis C virus infection.

  2012cites this paper
• The impact of hepatitis C virus donor and recipient status on long‐term kidney transplant outcomes: University of Wisconsin experience

  2012cites this paper
• Treatment of hepatitis C virus infection after kidney transplantation.

  2012cites this paper
• Long-Term Impact in Hepatitis C Virus Infection in Post Renal Transplantation

  2012cites this paper
• The influence of induction therapy for kidney transplantation after a non-renal transplant.

  2012cites this paper
• Clinical and immunological features of very long‐term survivors with a single renal transplant

  2012cites this paper
• Acquisition time: a key point of hepatitis C virus-related liver disease in renal transplant recipients.

  2012cites this paper
• Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients.

  2012cites this paper
• Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.

  2012cites this paper
• Expanding Opportunities for Kidney Transplantation

  2012cites this paper
• Infectious Complications in Kidney Transplantation

  2011cites this paper
• Impact of Hepatitis C Virus Infection on the Risk of Infectious Complications After Kidney Transplantation: Data From the RESITRA/REIPI Cohort

  2011cites this paper
• Management of HCV infection in chronic kidney disease.

  2011cites this paper
• Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience

  2011cites this paper
• The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies

  2011cites this paper
• Effect of kidney transplantation on outcomes among patients with hepatitis C.

  2011cites this paper
• Hepatitis C and Kidney Transplantation

  2011cites this paper
• Treatment of hepatitis C virus infection in patients with end‐stage renal disease

  2011cites this paper
• Viral hepatitis in solid organ transplantation other than liver.

  2011cites this paper
• Treatment issues surrounding hepatitis C in renal transplantation: a review.

  2011cites this paper
• The impact of Hepatitis C virus infection on kidney transplantation outcomes : A systematic review of 18 observational studies

  2011influential citation
• The impact of hepatitis C virus infection on long-term outcome in renal transplant patients.

  2011cites this paper
• Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy

  2011cites this paper
• Renal transplantation in patients with hepatitis C virus antibody. A long national experience

  2010cites this paper
• Successful Treatment of Hepatitis C Virus in a Renal Transplant Recipient; Case Report and Review of the Current Literature

  2010cites this paper
• Proteinuria among renal transplant patients and its relation to hepatitis C virus and graft outcome: a single center experience.

  2010cites this paper
• Influence of Preexisting Hepatitis C Virus Antibody Positivity in Simultaneous Pancreas-Kidney Transplant Recipients

  2010cites this paper
• Kidney grafts from HCV-positive donors: advantages and disadvantages.

  2010cites this paper